CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

MacroGenics expands ZYNYZ royalty deal with Sagard, secures $60M upfront

ZYNYZPositive
AI Analysis

Summary

MacroGenics expanded its ZYNYZ royalty deal with Sagard and secured $60M upfront payment. The transaction strengthens MacroGenics' financial position through expanded royalty arrangements on the marketed drug.

Importance:6/10
Sentiment:
0.60
licensingroyalty_expansioncash_proceeds
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on May 4, 2026 12:50 PM

Read Original